Hiv aids part 1[6]
Aug 2009 H I V Int Med Noon Lecture
ARV kombinasi
A daily dose of 400 mg efavirenz (EFV) is non-inferior to the standard 600 mg dose: week 48 data from the ENCORE1 study, a randomised, double-blind, placebo.
20th International AIDS Conference; July 20-25, 2014; Melbourne, Australia DTG-Based Regimens Are Active in INI-Naive Patients With a History of NRTI Resistance.
Interactive Workshop “HIV Cure 101”: Challenges in identifying and
Big Issues
INTRODUCTORY TALK D Costagliola. Chapter 1 THE CURRENT DEBATE ON ABACAVIR.
The 17th Conference on Retroviruses and Opportunistic Infections San Francisco, CA February 16-19, 2010.
Baseline Antiretroviral Resistance Testing among HIV-Positive Injection Drug Users in a Canadian Setting Nadia Fairbairn 1 M-J Milloy 1 Thomas Kerr 1,
Impact of HSV-2 suppressive therapy with daily acyclovir on HIV-1 disease progression: a randomized placebo- controlled trial in Rakai, Uganda Steven J.
Management of the Treatment Naïve Patient